Tangible evidence for a key role of complement in AD was provided in 2009, when two independent GWAS studies identified genes encoding clusterin and CR1 (and later C1S and C9) as significant risk factors to develop AD (139, 140, 176). The gene discussed is CLU; the disease is Alzheimer disease.